A Hitchhikers Guide to Anxiety Disorders


Anxiety disorders

How to Cite

Bamrah, J., Dow, F., Ramkisson, R., & Dave, S. (2023). A Hitchhikers Guide to Anxiety Disorders. The Physician, 8(1), 1-12. https://doi.org/10.38192/


AD is the commonest mental disorder with a lifetime prevalence rate of 21.1% in Europe, 31.0% in the United States2,3, a point prevalence of 5%, and a greater preponderance amongst women4.

Living with ADs can be a long-term challenge. In many cases, it occurs along with other mood disorders5,6. In most cases, AD improves with psychological therapies and medication. Making lifestyle changes, learning coping skills and using relaxation techniques also can help. However, failure to treat AD and its consequences can be economically and socially costly.

Therefore, early recognition of the disorder is imperative as that improves the scope for treatment and the prognosis. This guide describes critical aspects of the various subtypes of AD and how to manage them.




Hoyer, J., Becker, E.S. and Margraf J. Generalized anxiety disorder and clinical worry episodes in young women. Psychological Medicine, 2002, 32, 1227–1237. doi: 10.1017!S0033291702006360.

Kessler, R. C., Angermeyer, M., Anthony, J. C., De Graaf, R., Demyttenaere, K., Gasquet, I., … Üstün, T. B. Lifetime prevalence and age-of-onset distributions of mental disorders in the world health organisation’s world mental health survey initiative. World Psychiatry, 2007, 6(3), 168–176.

Wittchen, H. U., & Jacobi, F. Size and burden of mental disorders in Europe - a critical review and appraisal of 27 studies. In: European Neuropsychopharmacology, 2005, 15, pp. 357–376.

Hantsoo, L., and Epperson, C.N. Anxiety Disorders Among Women: A Female Lifespan Approach. Focus (Am Psychiatr Publ), 2017, 15(2): 162–172. Apr 6. doi:0.1176/appi.focus.20160042.

Kessler, R.C., Gruber ,M., Hettema, J.M., Hwang, I., Sampson, N., and Yonkers, K.A. Co-morbid major depression and generalized anxiety disorders in the National Comorbidity Survey follow-up. Psychological Medicine, 2008, 38:365–374. doi: 10.1017/S0033291707002012.

Cummings, C.M., Caporino, N.E., and Kendall, P.C. Comorbidity of anxiety and depression in children and adolescents: 20 years after. Psychol Bull., 2014, 140:816–845.

Kessler, R.C., Chiu, W.T., Jin, R., Ruscio, A.M., Shear, K., and Walters EE. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry, 2006, 63(4): 415–424. doi: 10.1001/archpsyc.63.4.415.

Massion, A.O., Warshaw, M.G., and Keller, M.B. Quality of life and psychiatric morbidity in panic disorder and generalized anxiety disorder. Am J Psychiatry, 1993, 150(4):600-7. doi: 10.1176/ajp.150.4.600.

Vesga-López, O., Schneier, F.R., Wang, S., et al. Gender differences in generalized anxiety disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry, 2008, 69:1606–1616.

Eaton, W.W., Kessler, R.C., Wittchen, H.-U., and Magee, W.J. Panic and panic disorder in the United States. Am J Psychiatry, 1994, 151:413-420. PMID: 8109651 DOI: 10.1176/ajp.151.3.413.

Joyce, P.R., Bushnell, J.A., Oakley-Browne, M.A., Wells, J.E., Hornblow, A.R. The epidemiology of panic symptomatology and agoraphobic avoidance. Comprehensive Psychiatry, 1989, 30:303-312.

Kessler, R.C., Petukhova, M., Sampson, N.A., Zaslavsky, A.M., Wittchen, H.-U. Twelve‐month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res., 2012, 21(3): 169–184. doi: 10.1002/mpr.1359.

Furmark, T., Tillfors, M., Everz, P.-O., et al. Social phobia in the general population: prevalence and sociodemographic profile. Soc Psychiatry Epidemiol 1999; 34:416-424.

Magee, W.J., Eaton, W.W., Wittchen, H.-U., McGonagle, K.A., and Kessler, R.C. Agoraphobia, simple phobia, and social phobia in the National Comorbidity survey. Arch Gen Psych, 1996, 53: 159-168.

Looper, K. and Dickinson P. Epidemiological and Economic Aspects of Hypochondriasis and Health Anxiety. In: Hypochondriasis and Health Anxiety: A Guide for Clinicians. Editors: Starcevic V. and Noyes R. jr. Oxford University Press, 2014, Ch. 6, 85-112.

Tyrer P., Cooper S. and Bassett, P. Increase in the prevalence of health anxiety in medical clinics: Possible cyberchondria. International Journal of Social Psychiatry, 2019, Vol. 65, Issue 7-8, doi.org/10.1177/0020764019866231.

Norbye, A. D., Abelsen, B., Førde, O.H. and Ringberg, U. Health anxiety is an important driver of healthcare use. BMC Health Services Research, 2022, Vol. 22, Article number: 138.

Rief, W., Buhlmann, U., Wilhelm, S., Borkenhagen, A., and Brähler, A. The prevalence of body dysmorphic disorder: a population-based survey. Psychol Med. 2006, Jun;36(6):877-85. doi: 10.1017/S0033291706007264.

Bjornsson, A.S., Didie, R.D. and Phillips K.A. Body dysmorphic disorder. Dialogues Clin Neurosci. 2010 Jun; 12(2): 221–232. doi: 10.31887/DCNS.2010.12.2/abjornsson

Fenske, J.N., and Petersen, K. Obsessive-Compulsive Disorder: Diagnosis and Management. Am Fam Physician, 2015, 92, 896-903.

Roper, G. and Rachman, S. Obsessional-compulsive checking: experimental replication and development. Behav Res Ther, 1976, 14, 25-32.

Sahoo, P., Sethy, R. R. and Ram, D. Functional Impairment and Quality of Life in Patients with Obsessive Compulsive Disorder. Indian J Psychol Med, 2017, 39, 760-765.

Markarian, Y., Larson, M. J., Aldea, M. A., Baldwin, S. A., Good, D., Berkeljon, A., Murphy, T. K., Storch, E. A. & Mckay, D. Multiple pathways to functional impairment in obsessive-compulsive disorder. Clin Psychol Rev, 2010, 30, 78-88.

McCarty, R., Guzick, A., Swan, L. & McNamara, J. Stigma and recognition of different types of symptoms in OCD. Journal of Obsessive-Compulsive and Related Disorders, 2016, 12, 64-70.

Krebs, G. and Heyman, I. Obsessive-compulsive disorder in children and adolescents. Archives of Disease in Childhood, 2015, 100, 495.

Brakoulias, V., Starcevic, V., Belloch, A., Brown, C., Ferrao, Y. A., Fontanelle, L. F., Lochner, C., Marazziti, D., Matsunaga, H., Miguel, E. C., Reddy, Y. C. J., Do Rosario, M. C., Shavitt, R. G., Shyam Sundar, A., Stein, D. J., Torres, A. R. and Viswasam, K. Comorbidity, age of onset and suicidality in obsessive-compulsive disorder (OCD): An international collaboration. Compr Psychiatry, 2017, 76, 79-86.

Sharma, E., Sharma, L. P., Balachander, S., Lin, B., Manohar, H., Khanna, P., Lu, C., Garg, K., Thomas, T. L., Au, A. C. L., Selles, R. R., Hojgaard, D., Skarphedinsson, G. and Stewart, S. E. Comorbidities in Obsessive-Compulsive Disorder Across the Lifespan: A Systematic Review and Meta-Analysis. Front Psychiatry, 2021, 12, 703701.

Eisen, J. L., Sibrava, N. J., Boisseau, C. L., Mancbo, M. C., Stout, R. L., Pinto, A. & Rasmussen, S. A. Five-year course of obsessive-compulsive disorder: predictors of remission and relapse. J Clin Psychiatry, 2013, 74, 233-9.

Fineberg, N. A., Hengartner, M. P., Bergbaum, C., Gale, T., Rossler, W. and Angst, J. Remission of obsessive-compulsive disorders and syndromes; evidence from a prospective community cohort study over 30 years. Int J Psychiatry Clin Pract, 2013, 17, 179-87.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2023 Array